Literature DB >> 12798334

High-affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus.

Han Cheng Zhang1, Kimberly B White, David F McComsey, Michael F Addo, Patricia Andrade-Gordon, Claudia K Derian, Donna Oksenberg, Bruce E Maryanoff.   

Abstract

A new generation of indole-based peptide mimetics, bearing a basic amine at the C-terminus, was developed by the agency of two complementary, multistep, trityl resin-based approaches. Thus, we obtained several high-affinity thrombin receptor (PAR-1) ligands, such as 32 and 34. Compounds 32 and 34 were found to bind to PAR-1 with excellent affinity (IC(50)=25 and 35 nM, respectively) and to effectively block platelet aggregation induced by SFLLRN-NH(2) (TRAP-6) and alpha-thrombin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798334     DOI: 10.1016/s0960-894x(03)00325-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.

Authors:  Disha M Gandhi; Mark W Majewski; Ricardo Rosas; Kaitlin Kentala; Trevor J Foster; Eric Greve; Chris Dockendorff
Journal:  Bioorg Med Chem       Date:  2018-04-06       Impact factor: 3.641

2.  Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar.

Authors:  Mariappan V Chelliah; Samuel Chackalamannil; Yan Xia; William J Greenlee; Ho-Sam Ahn; Stan Kurowski; George Boykow; Yunsheng Hsieh; Madhu Chintala
Journal:  ACS Med Chem Lett       Date:  2013-12-18       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.